protocolSection identificationModule nctId: NCT06334068, orgStudyIdInfo id: MS.24.03.2725, briefTitle: SHOrt-term Glycemic Control for Reducing Post-SURGical Complications, acronym: Surg-ShoGR, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03, primaryCompletionDateStruct date: 2024-09, completionDateStruct date: 2024-10, studyFirstPostDateStruct date: 2024-03-27, lastUpdatePostDateStruct date: 2024-03-27, sponsorCollaboratorsModule leadSponsor name: Mansoura University, class: OTHER, descriptionModule briefSummary: Perioperative dysglycemia-hyperglycemia, hypoglycemia, and glycemic variability-is associated with an increased risk for adverse outcomes. Several studies have reported the association between elevated preoperative HbA1c and postoperative complications.There are no studies that confirm that postponing elective surgery improves patient outcomes. Likewise, no prospective trials have studied whether short-term glycemic control reduces postoperative complications and unnecessary patient delays in elective surgeries.Consequently, we designed a randomized controlled trial to investigate the effects of short-term glycemic control before major abdominal surgery on postoperative morbidity and mortality., conditionsModule conditions: Diabetes, conditions: Uncontrolled Diabtetes, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: The patients in the preoperative anesthesia clinic are divided into one of the following groups:1. Short-term glycemic control group:   Patients will be admitted to the hospital for 2-3 days before surgery. During this pilot study, patients will be admitted to the intermediate care unit to monitor and control preoperative blood glucose. We aim to maintain moderate glucose control (140 - 180 mg/dl) using basal-bolus insulin protocol plus correctional doses as needed.2. Standard-of-care group: Patients will be admitted the day before surgery with the usual patient treatment., primaryPurpose: PREVENTION, maskingInfo masking: SINGLE, maskingDescription: The outcome assessors, who will call patients or relatives 30 days after surgery, will be masked for the allocated group., whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 60, type: ESTIMATED, armsInterventionsModule interventions name: Short-term glycemic control group, interventions name: Standard-of-care group, outcomesModule primaryOutcomes measure: Number of days at home after surgery (DAH-30)., secondaryOutcomes measure: Loss of follow-up after surgery, secondaryOutcomes measure: Loss of follow up after the clinic preoperative assessment, secondaryOutcomes measure: 30-day mortality, secondaryOutcomes measure: Length of hospital stay, secondaryOutcomes measure: incidence of postoperative complications, secondaryOutcomes measure: Quality of Recovery15 (QoR-15), otherOutcomes measure: Time to resumption of normal diabetes therapy, otherOutcomes measure: Incidence of diabetic ketoacidosis or hypoglycemia, otherOutcomes measure: Incidence of use of intravenous insulin infusion therapy, otherOutcomes measure: Duration of use of intravenous insulin infusion therapy, otherOutcomes measure: Change in diabetic management at 30 days, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Moataz Maher Emara, city: Mansoura, state: Aldakahlia, zip: 35516, country: Egypt, contacts name: Moataz M Emara, MD, EDAIC, role: CONTACT, phone: 01064048848, email: mm.emara@mans.edu.eg, geoPoint lat: 31.03637, lon: 31.38069, hasResults: False